pmid	title_e	journal
34979577	[Mania after COVID-19 Infection].	Psychiatr Prax
34978377	"Reply to ""Post-COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia""."	Alzheimers Dement
34974434	Telemedicine in French Memory Clinics During the COVID-19 Pandemic.	J Alzheimers Dis
34973027	Cognitive Enhancement Through Mathematical Problem-Solving.	Adv Exp Med Biol
34971298	Being a frail older person at the time of the COVID-19 pandemic.	Alzheimers Dement
34971296	Caring for residents with dementia during a COVID-19 outbreak in a long-term care home.	Alzheimers Dement
34971293	Addressing dementia challenges through international networks: Evidence from the Latin American and Caribbean Consortium on Dementia (LAC-CD).	Alzheimers Dement
34971289	Telehealth outreach programming in the Pacific island of Guam: Providing access to dementia care support services during the COVID-19 pandemic.	Alzheimers Dement
34971287	Dissemination of person-centered community care for mild dementia using local cooperatives in Korea during the COVID-19 pandemic.	Alzheimers Dement
34971285	Effectiveness of home-based telerehabilitation in mild to moderate Alzheimer's disease: A randomised controlled study.	Alzheimers Dement
34971276	Development and dissemination of an ethical guidance and person-centred isolation care planning tool to support the care of people with dementia during the COVID-19 pandemic.	Alzheimers Dement
34971269	UW Project ECHO-Dementia: Implementation of a virtual clinic and telementoring program to improve dementia diagnosis and treatment in rural and under-resourced primary care settings.	Alzheimers Dement
34971266	Person-centered care for family caregivers of people living with dementia: Co-designing an education program for the healthcare workforce.	Alzheimers Dement
34971258	Efficacy of cognitive stimulation therapy virtual program for older adults with dementia in COVID-19 isolation.	Alzheimers Dement
34971256	Lessons from COVID-19 pandemic: Clinical experiences on telemedicine in patients with dementia in Iran.	Alzheimers Dement
34971254	Assessing cognition in the era of COVID19: Do we need methods to assess cognitive function virtually?	Alzheimers Dement
34971249	Fighting social isolation of vulnerable people with dementia through remote group meetings: An experience report.	Alzheimers Dement
34971248	With challenge comes opportunity: Dementia care innovations made in senior living during COVID that will outlast the pandemic.	Alzheimers Dement
34971245	Tactics, teaching and transitioning: Response to the COVID-19 pandemic in the nursing home sector.	Alzheimers Dement
34971241	Clinical experience with polygenic risk score in subjects with early cognitive concerns.	Alzheimers Dement
34971235	Home care becoming essential during pandemic.	Alzheimers Dement
34971221	Patient experience and satisfaction with remote memory assessment: Responding to clinical need in times of COVID-19 restrictions.	Alzheimers Dement
34971212	Feasibility of multidisciplinary telehealth evaluations in atypical dementia.	Alzheimers Dement
34971120	Home monitoring of daily living activities and prediction of agitation risk in a cohort of people living with dementia.	Alzheimers Dement
34971113	Remote cognitive rehabilitation in patients post-cerebrovascular accident: an experience report.	Alzheimers Dement
34971112	ReMember-Me system: Developing a new, remote digital tool for detecting and preventing cognitive decline.	Alzheimers Dement
34971109	Feasibility and evaluation of the Dementia Engagement Modelling Program (DEMP): a novel model of aged care during COVID-19.	Alzheimers Dement
34971091	The impact of presentation modality on cognitive test performance for adults with hearing loss.	Alzheimers Dement
34971088	Effect of COVID-19 on BPSD severity and caregiver distress: Trend data from national dementia-specific behavior support programs in Australia.	Alzheimers Dement
34971087	Latin American Older people and neuropsychiatric symptoms: a mini-systematic review of effects of COVID-19 Pandemic.	Alzheimers Dement
34971068	Developing a digital assistive tool for dementia patients and their caregivers: A qualitative study on needs, potential functions, practical requirements, user acceptance, and ethical considerations.	Alzheimers Dement
34971061	LifeBio memory's technology advancements for capturing life stories and seeing the whole person.	Alzheimers Dement
34971057	Patient attitudes towards remote memory clinic assessment.	Alzheimers Dement
34971052	Leveraging virtual reality to train certified nursing assistants as essential dementia-care personnel in the age of COVID-19.	Alzheimers Dement
34971048	Technology-driven dyadic interaction in caregiving.	Alzheimers Dement
34971042	Smartphone ownership and usage in Chinese- and English-speaking older adults.	Alzheimers Dement
34971039	Type and frequency of social contacts associated with low mood before and during the COVID-19 pandemic in older adults: I-CONECT project.	Alzheimers Dement
34971035	Health care professionals and use of digital technologies in patients with dementia and related disorders.	Alzheimers Dement
34971033	Seas the day: Co-designing immersive virtual reality exergames with exercise professionals and people living with dementia.	Alzheimers Dement
34967216	Graphene-based Nanomaterials in Fighting the Most Challenging Viruses and Immunogenic Disorders.	ACS Biomater Sci Eng
34966022	Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-19.	Alzheimer Dis Assoc Disord
34951387	Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.	Curr Neuropharmacol
34948400	SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.	Int J Mol Sci
34945251	How COVID-19 Has Affected Caregivers' Burden of Patients with Dementia: An Exploratory Study Focusing on Coping Strategies and Quality of Life during the Lockdown.	J Clin Med
34942927	Effect of Sensory Deprivation of Nasal Respiratory on Behavior of C57BL/6J Mice.	Brain Sci
34942135	Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial.	Lancet Neurol
34930444	Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study.	Alzheimers Res Ther
34926365	Alzheimer's Association Project VITAL: A Florida Statewide Initiative Using Technology to Impact Social Isolation and Well-Being.	Front Public Health
34917575	A Framework of AI-Based Approaches to Improving eHealth Literacy and Combating Infodemic.	Front Public Health
34907696	Apolipoprotein E4 as a Novel Treatment Target for Alzheimer's Disease.	Cell Physiol Biochem
34907049	Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study.	BMJ Open
34902662	Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2.	Epilepsy Behav
34886772	Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation.	Curr Alzheimer Res
34875696	Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer's Disease Prevention.	Pharmacopsychiatry
34874605	Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.	Alzheimers Dement
34867295	The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin.	Front Aging Neurosci
34864549	Docosahexaenoic acid-containing phosphatidic acid interacts with clathrin coat assembly protein AP180 and regulates its interaction with clathrin.	Biochem Biophys Res Commun
34833630	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics.	Sensors (Basel)
34833377	COVID-19 and Alzheimer's Disease: A Literature Review.	Medicina (Kaunas)
34831271	Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases.	Cells
34831104	Instructions for Flow Cytometric Detection of ASC Specks as a Readout of Inflammasome Activation in Human Blood.	Cells
34812418	COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings.	IEEE Open J Eng Med Biol
34810241	I Wasn't There: Caring for a Patient With Trisomy 21, Alzheimer Disease, and Epilepsy Until His Final Days With COVID-19.	Neurology
34806608	Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.	J Alzheimers Dis
34803804	"Brain Fog"" by COVID-19 or Alzheimer's Disease? A Case Report.	Front Psychol
34794709	Hospital staff members' preferences about who should be prioritized to receive the COVID-19 vaccine: People with or without Alzheimer's disease?	J Aging Stud
34776448	Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort.	J Alzheimers Dis
34776447	Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.	J Alzheimers Dis
34755917	Quality of life, mood, and cognitive performance in older adults with cognitive impairment during the first wave of COVID 19 in Argentina.	Int J Geriatr Psychiatry
34755047	Induction of Gut Microbial Tryptamine by SARS-CoV-2 in Nonhuman Primate Model Consistent with Tryptamine-Induced Model of Neurodegeneration.	J Alzheimers Dis Rep
34745371	Deep Learning Approach for Early Detection of Alzheimer's Disease.	Cognit Comput
34745215	Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer's Disease Patients Group Brain Using Genome-Wide Association Study Approach.	Front Genet
34735712	Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.	Adv Exp Med Biol
34728300	Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensors.	Int J Biol Macromol
34721498	Prevalence of Dementia and Associated Factors among Older Adults in Latin America during the COVID-19 Pandemic.	Dement Geriatr Cogn Dis Extra
34713183	The Internet-Based Conversational Engagement Clinical Trial (I-CONECT) in Socially Isolated Adults 75+ Years Old: Randomized Controlled Trial Protocol and COVID-19 Related Study Modifications.	Front Digit Health
34703976	Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development and Adoption.	Digit Biomark
34692984	Impact of the COVID-19 pandemic on use of anti-dementia medications in 34 European and North American countries.	Alzheimers Dement (N Y)
34690147	COVID-19 Case Fatality and Alzheimer's Disease.	J Alzheimers Dis
34680478	CK2 Regulation: Perspectives in 2021.	Biomedicines
34675597	Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence.	J Inflamm Res
34671250	The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.	Front Aging Neurosci
34669085	Correction to: Alzheimer's disease in elderly COVID19 patients: potential mechanisms and preventive measures.	Neurol Sci
34664262	Patterns of incident dementia codes during the COVID-19 pandemic at an integrated healthcare system.	J Am Geriatr Soc
34655901	Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities.	Comput Biol Med
34647635	Association between molecular markers of COVID-19 and Alzheimer's disease.	J Med Virol
34647482	Implications of the COVID-19 Pandemic on Adult Day Services and the Families They Serve.	Am J Alzheimers Dis Other Demen
34633054	Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review).	Mol Med Rep
34629131	Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD).	Int Psychogeriatr
34628788	Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.	Folia Neuropathol
34621898	Bibliometric Analysis on Geriatric Nursing Research in Web of Science (1900-2020).	Biomed Res Int
34621377	The impact of the SARS-CoV-2 pandemic on the mental health of hemodialysis patients in Lebanon.	J Med Life
34619763	A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.	Brain
34606321	Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020.	Ann Intern Med
34602467	Virtual Reality Experience Intervention May Reduce Responsive Behaviors in Nursing Home Residents with Dementia: A Case Series.	J Alzheimers Dis
34596318	Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic.	Alzheimers Dement
34587403	Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19.	J Environ Pathol Toxicol Oncol
34585227	Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.	J Prev Alzheimers Dis
34575321	Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galati County.	J Clin Med
34573186	Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study.	Brain Sci
34573148	Psychological and Emotional Effects of Digital Technology on Children in COVID-19 Pandemic.	Brain Sci
34562355	Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases.	Cell Metab
34556345	The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.	Rev Neurol (Paris)
34551846	The N(th) Wave of COVID-19: Will It Be Alzheimer's?	Can J Neurol Sci
34550494	Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.	Neurol Sci
34545717	[Prospects for using low-dose radiation in the complex therapy for COVID-19].	Vopr Virusol
34542068	Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19.	J Alzheimers Dis
34541458	Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination.	SN Compr Clin Med
34525524	Active elasticity drives the formation of periodic beading in damaged axons.	Phys Rev E
34525328	Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease.	Neuron
34514341	Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging.	J Alzheimers Dis Rep
34511868	Neurological sequelae of COVID-19: a review.	Egypt J Neurol Psychiatr Neurosurg
34502105	microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).	Int J Mol Sci
34489776	Face Masks Protect From Infection but May Impair Social Cognition in Older Adults and People With Dementia.	Front Psychol
34487051	Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies.	J Alzheimers Dis
34484498	Improving End-of-Life Care for People with Dementia in LTC Homes During the COVID-19 Pandemic and Beyond.	Can Geriatr J
34482635	Post-COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia.	Alzheimers Dement
34480857	Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.	Lancet Infect Dis
34476120	SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer's disease.	J Alzheimers Dis Parkinsonism
34464365	[Status of everyday activities and cognitive activity in elderly patients with symptoms of Alzheimer's dementia during COVID-19].	Pol Merkur Lekarski
34463994	Oral health's inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions.	Periodontol 2000
34454957	A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.	J Infect
34449649	Dementia Caregiver Virtual Support-An Implementation Evaluation of Two Pragmatic Models during COVID-19.	Geriatrics (Basel)
34447712	Meningoencephalitis Associated with SARS-Coronavirus-2.	Transl Med UniSa
34442332	Tele-Neuropsychological Assessment of Alzheimer's Disease.	J Pers Med
34439052	Synthesis of Antimicrobial Benzimidazole-Pyrazole Compounds and Their Biological Activities.	Antibiotics (Basel)
34434913	Preexisting Mental Disorders Increase the Risk of COVID-19 Infection and Associated Mortality.	Front Public Health
34432371	Population-based assessment of risks for severe COVID-19 disease outcomes.	Influenza Other Respir Viruses
34420971	High Exhaustion in Geriatric Healthcare Professionals During the COVID-19 Second Lockdown.	J Alzheimers Dis
34416114	Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.	Am J Alzheimers Dis Other Demen
34414876	Implication of COVID-19 on neurological complications with specific emphasis on alzheimer's and parkinson's disease.	CNS Neurol Disord Drug Targets
34406390	Immunoinflammatory role of apolipoprotein E4 in malnutrition and enteric infections and the increased risk for chronic diseases under adverse environments.	Nutr Rev
34401683	Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.	EClinicalMedicine
34393864	The Impact of the COVID-19 Pandemic and Lockdown on Mild Cognitive Impairment, Alzheimer's Disease and Dementia With Lewy Bodies in China: A 1-Year Follow-Up Study.	Front Psychiatry
34389387	Brilliant glycans and glycosylation: Seq and ye shall find.	Int J Biol Macromol
34384490	Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.	Alzheimers Res Ther
34383681	Repeated Transcranial Magnetic Stimulation for Improving Cognition in Alzheimer Disease: Protocol for an Interim Analysis of a Randomized Controlled Trial.	JMIR Res Protoc
34368778	A Cautionary Note for COVID-19 Survivors: Potential Long-term Risk for Alzheimer's Disease.	Am J Biomed Sci Res
34367054	SARS-CoV-2 Susceptibility and COVID-19 Mortality Among Older Adults With Cognitive Impairment: Cross-Sectional Analysis From Hospital Records in a Diverse US Metropolitan Area.	Front Neurol
34360989	The Effects of Abeta1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2.	Int J Mol Sci
34358472	Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.	Lancet Child Adolesc Health
34342415	Fitness training programs for Alzheimer's disease patients during the COVID-19 pandemic.	J Sports Med Phys Fitness
34335338	The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias.	Front Psychiatry
34334333	Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study.	Lancet Digit Health
34312772	Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection.	Mol Neurobiol
34312610	Saffron for ""toning down"" COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence.	Metabol Open
34308909	The Effect of Prolonged Lockdown Due to COVID-19 on Greek Demented Patients of Different Stages and on Their Caregivers.	J Alzheimers Dis
34305135	Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid beta and Tau Protein.	Med Sci Monit
34305035	Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.	Lancet Digit Health
34299756	The Long-Term Public Health Impact of Social Distancing on Brain Health: Topical Review.	Int J Environ Res Public Health
34295959	Current advances in digital cognitive assessment for preclinical Alzheimer's disease.	Alzheimers Dement (Amst)
34276349	Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome.	Front Aging Neurosci
34274727	Molecular insight on the formation structure and dynamics of melatonin in an aqueous solution and at the Water-Air interface: A molecular dynamics study.	J Mol Graph Model
34274565	Recent advances in drug repurposing using machine learning.	Curr Opin Chem Biol
34261836	The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.	Biosci Trends
34256334	Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran.	Parkinsonism Relat Disord
34250939	Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring$.	J Alzheimers Dis
34249938	The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.	Front Cell Dev Biol
34245485	Delirium in a patient with Alzheimer's dementia following COVID-19 vaccination.	Psychogeriatrics
34242809	Can healthy lifestyle reduce disease progression of Alzheimer's during a global pandemic of COVID-19?	Ageing Res Rev
34238568	Loneliness of residents in retirement homes during the COVID-19 crisis.	Encephale
34238345	Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.	Alzheimers Res Ther
34238041	Update on Neurodegenerative Diseases and Glutamate: A PMHNP Single Case Study Report of a Diagnostically Complex Adult Patient, Interventions, and Unexpected Outcomes.	J Am Psychiatr Nurses Assoc
34223998	Neurodegenerative proteinopathies associated with neuroinfections.	J Neural Transm (Vienna)
34222864	Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force.	Brain Commun
34219720	Supporting and Protecting People with Dementia in the COVID-19 Pandemic.	J Alzheimers Dis
34217888	An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic.	Contemp Clin Trials
34209586	NLRP3 and Infections: beta-Amyloid in Inflammasome beyond Neurodegeneration.	Int J Mol Sci
34208136	NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.	Medicina (Kaunas)
34200720	Specific Treatment Exists for SARS-CoV-2 ARDS.	Vaccines (Basel)
34191932	Impact of Confinement on the Burden of Caregivers of Patients with the Behavioral Variant of Frontotemporal Dementia and Alzheimer Disease during the COVID-19 Crisis in France.	Dement Geriatr Cogn Dis Extra
34184343	Potential neurobiological links between social isolation and Alzheimer's disease risk.	Eur J Neurosci
34180617	[Vaccine against COVID-19].	Rev Esp Quimioter
34176427	Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.	Postgrad Med
34176095	COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.	Mol Neurobiol
34173049	Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.	Eur Arch Psychiatry Clin Neurosci
34172985	The challenges of the COVID-19 pandemic: Approaches for the elderly and those with Alzheimer's disease.	MedComm (2020)
34169443	Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.	Mol Neurobiol
34166841	Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.	Contemp Clin Trials
34164564	Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).	CellR4 Repair Replace Regen Reprogram
34145669	COVID-19-related neuropathology and microglial activation in elderly with and without dementia.	Brain Pathol
34132180	Recent Advances in the Discovery of Antiviral Metabolites from Fungi.	Curr Pharm Biotechnol
34118974	Severe COVID-19 in Alzheimer's disease: APOE4's fault again?	Alzheimers Res Ther
34118414	7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19.	J Steroid Biochem Mol Biol
34115612	The key role of the level of ACE2 gene expression in SARS-CoV-2 infection.	Aging (Albany NY)
34112355	Zinc.	Adv Food Nutr Res
34108016	Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.	Alzheimers Res Ther
34101797	Can Virtual Scientific Conferences Facilitate Two-Way Learning between Dementia Researchers and Participants?	J Prev Alzheimers Dis
34092646	Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.	J Alzheimers Dis
34092637	Mental Health of People with Dementia During COVID-19 Pandemic: What Have We Learned from the First Wave?	J Alzheimers Dis
34090221	Examining hospital staff members' preferences for allocating a ventilator to a COVID-19 patient with and without Alzheimer's disease.	Geriatr Nurs
34089149	Hallucinations and Covid-19: Increased Occurrence of Hallucinations in Patients with Alzheimer's Disease During Lockdown.	Psychiatr Q
34079609	Social Connection is Essential in Long-Term Care Homes: Considerations During COVID-19 and Beyond.	Can Geriatr J
34055724	""We Don't Feel so Alone"": A Qualitative Study of Virtual Memory Cafes to Support Social Connectedness Among Individuals Living With Dementia and Care Partners During COVID-19.	Front Public Health
34027023	Change in modifiable dementia risk factors during COVID-19 lockdown: The experience of over 50s in Tasmania, Australia.	Alzheimers Dement (N Y)
34019093	Karyopherin abnormalities in neurodegenerative proteinopathies.	Brain
34018966	Psychometric Evaluation and Workflow Integration Study of a Tablet-Based Tool to Detect Mild Cognitive Impairment in Older Adults: Protocol for a Mixed Methods Study.	JMIR Res Protoc
34017039	Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection.	Sci Rep
34013019	The need for psychological, caregiver-centered intervention in the time of COVID-19.	Alzheimers Dement (N Y)
34006157	Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.	Palliat Med
34002836	Different approaches to the analysis of causes of death during the COVID-19 epidemic.	Eur Rev Med Pharmacol Sci
33998537	Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.	J Alzheimers Dis
33978366	Comparison of Clinical, Laboratory and Demographic Characteristics of Patients Diagnosed with COVID-19 as Symptomatic and Atypical Symptoms.	Clin Lab
33977807	Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.	J Diet Suppl
33973880	An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease.	Alzheimer Dis Assoc Disord
33960399	Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences.	J Am Geriatr Soc
33953663	Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies.	Front Hum Neurosci
33941272	COVID-19 and Alzheimer's disease: how one crisis worsens the other.	Transl Neurodegener
33935943	Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions.	Front Neurol
33934422	Predictable fold switching by the SARS-CoV-2 protein ORF9b.	Protein Sci
33922673	Needs of Alzheimer's Charges' Caregivers in Poland in the Covid-19 Pandemic-An Observational Study.	Int J Environ Res Public Health
33922634	A Non-Linear Biostatistical Graphical Modeling of Preventive Actions and Healthcare Factors in Controlling COVID-19 Pandemic.	Int J Environ Res Public Health
33906383	A novel capsule-based smell test fabricated via coaxial dripping.	J R Soc Interface
33901048	Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19.	Alzheimer Dis Assoc Disord
33897503	NMDAR Neurotransmission Needed for Persistent Neuronal Firing: Potential Roles in Mental Disorders.	Front Psychiatry
33897410	Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases.	Front Aging Neurosci
33896844	Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown.	J Alzheimers Dis
33892139	Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.	Brain Behav Immun
33886614	High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.	PLoS One
33881211	Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.	Alzheimers Dement
33857453	Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.	Lancet Public Health
33855161	Dementia or psychosis precipitated by social isolation? A brief case report in COVID-19 pandemic times.	Alzheimers Dement (Amst)
33853394	Impact of COVID-19 on Dementia Caregivers and Factors Associated With their Anxiety Symptoms.	Am J Alzheimers Dis Other Demen
33838684	COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients.	Alzheimers Res Ther
33829974	C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System.	Curr Neuropharmacol
33829025	Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates.	Front Med (Lausanne)
33817671	Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease.	Brain Behav Immun Health
33814449	Dementia-Friendly ""Design"": Impact on COVID-19 Death Rates in Long-Term Care Facilities Around the World.	J Alzheimers Dis
33814446	Impact of Social Isolation on People with Dementia and Their Family Caregivers.	J Alzheimers Dis
33803913	Understanding Social Behaviour in a Health-Care Facility from Localization Data: A Case Study.	Sensors (Basel)
33802718	Human Body-Related Disease Diagnosis Systems Using CMOS Image Sensors: A Systematic Review.	Sensors (Basel)
33782667	Online Personalised Training in Memory Strategies for Everyday (OPTIMiSE) Program for Older Adults with Cognitive Concerns: Pilot Study Protocol.	J Alzheimers Dis Rep
33781272	The rise and fall of global health issues: an arenas model applied to the COVID-19 pandemic shock.	Global Health
33774195	Attenuation of 7-ketocholesterol- and 7beta-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: Potential for the prevention of age-related diseases.	Ageing Res Rev
33756057	2021 Alzheimer's disease facts and figures.	Alzheimers Dement
33749656	Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.	J Alzheimers Dis
33748394	Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment.	Alzheimers Dement (Amst)
33738333	Impact of the COVID-19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World-Wide FINGERS.	Alzheimers Dement (N Y)
33722828	Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond.	CMAJ
33720900	Is the Frontal Lobe the Primary Target of SARS-CoV-2?	J Alzheimers Dis
33720839	Impact of the COVID-19 Pandemic on Older Adults: Rapid Review.	JMIR Aging
33706965	Melatonin and healthy aging.	Vitam Horm
33704074	Effect of Reading Rehabilitation for Age-Related Macular Degeneration on Cognitive Functioning: Protocol for a Nonrandomized Pre-Post Intervention Study.	JMIR Res Protoc
33687889	Persons with co-existing neurological disorders: Risk analysis, considerations and management in COVID-19 pandemic.	CNS Neurol Disord Drug Targets
33674185	SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.	Cytokine Growth Factor Rev
33673697	COVID-19 and Alzheimer's Disease.	Brain Sci
33668641	Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians.	Brain Sci
33665943	Family caregivers of patients with Alzheimer's disease during the COVID-19 journey.	Jpn J Nurs Sci
33660221	Specific Susceptibility to COVID-19 in Adults with Down Syndrome.	Neuromolecular Med
33646169	Separate and Unequal: A Time to Reimagine Dementia.	J Alzheimers Dis
33646168	Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.	J Alzheimers Dis
33646163	COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.	J Alzheimers Dis
33632092	CAR (Current Alzheimer Research) has a ROAD (Research on AD) Even in the Lockdown.	Curr Alzheimer Res
33581812	New global initiative to tackle Alzheimer's disease.	Lancet
33571481	A certain proportion of docosahexaenoic acid tends to revert structural and dynamical effects of cholesterol on lipid membranes.	Biochim Biophys Acta Biomembr
33567524	Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.	Int J Mol Sci
33563186	COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods.	Anticancer Agents Med Chem
33561190	Validity of In-Home Teleneuropsychological Testing in the Wake of COVID-19.	Arch Clin Neuropsychol
33559975	COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.	Alzheimers Dement
33554916	Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.	J Alzheimers Dis
33554905	The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.	J Alzheimers Dis
33550782	CNS implications of COVID-19: a comprehensive review.	Rev Neurosci
33546262	Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?	Nutrients
33543541	Alzheimer's Association Update.	Alzheimers Dement
33539089	Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.	J Med Chem
33536898	The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey.	Front Aging Neurosci
33536883	Digging Signatures in 13-Month-Old 3xTg-AD Mice for Alzheimer's Disease and Its Disruption by Isolation Despite Social Life Since They Were Born.	Front Behav Neurosci
33532701	The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer's Disease and Aging: A Review of Knowledge.	J Alzheimers Dis Rep
33530357	Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study.	Geriatrics (Basel)
33521641	BIN1 rs744373 SNP and COVID-19 mortality.	World Acad Sci J
33507660	[Recent Advances in Neurology].	Rev Med Suisse
33502593	Viral infections and their relationship to neurological disorders.	Arch Virol
33496862	Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.	J Neurol
33492297	The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science.	J Alzheimers Dis
33490361	Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research.	Alzheimers Dement (N Y)
33465108	Feasibility and validation of a web-based platform for the self-administered patient collection of demographics, health status, anxiety, depression, and cognition in community dwelling elderly.	PLoS One
33459706	Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.	J Alzheimers Dis
33457322	Meningoencephalitis Associated with SARS-Coronavirus-2.	Transl Med UniSa
33450186	ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.	Cell Stem Cell
33422806	Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?	Med Hypotheses
33420609	COVID-19 Hospitalization by Race and Ethnicity: Association with Chronic Conditions Among Medicare Beneficiaries, January 1-September 30, 2020.	J Racial Ethn Health Disparities
33416619	Varieties of Experiences of Care.	Perspect Biol Med
33409824	Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations.	Neurol Sci
33399270	The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.	Alzheimers Dement
33395100	Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?	Curr Opin Psychiatry
33386809	Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.	J Alzheimers Dis
33380791	Laypersons' Priority-Setting Preferences for Allocating a COVID-19 Patient to a Ventilator: Does a Diagnosis of Alzheimer's Disease Matter?	Clin Interv Aging
33380345	Cognitive impact of COVID-19: looking beyond the short term.	Alzheimers Res Ther
33344748	Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID-19 pandemic: Commentary on the virtual administration of the ADAS-Cog.	Alzheimers Dement (N Y)
33341456	Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer's disease in COVID-19 patients.	Clin Neurol Neurosurg
33338751	Myricetin: A review of the most recent research.	Biomed Pharmacother
33329337	Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment.	Front Neurol
33329110	Impact of Social Isolation on the Behavioral, Functional Profiles, and Hippocampal Atrophy Asymmetry in Dementia in Times of Coronavirus Pandemic (COVID-19): A Translational Neuroscience Approach.	Front Psychiatry
33329097	Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World.	Front Psychiatry
33328588	Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.	Mol Psychiatry
33323916	Psychiatric Manifestations of COVID-19 and Their Social Significance.	Med Sci Monit
33322696	Home-Based Care for People with Alzheimer's Disease and Related Dementias (ADRD) during COVID-19 Pandemic: From Challenges to Solutions.	Int J Environ Res Public Health
33316174	Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020.	Ann Intern Med
33307726	Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.	Am J Alzheimers Dis Other Demen
33304284	How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis.	Front Psychiatry
33295781	The Effects of COVID-19 Home Confinement in Dementia Care: Physical and Cognitive Decline, Severe Neuropsychiatric Symptoms and Increased Caregiving Burden.	Am J Alzheimers Dis Other Demen
33285638	The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis.	J Alzheimers Dis
33283188	The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease.	Neurosci Insights
33283166	Hallucinations in a Patient with Alzheimer's Disease During the COVID-19 Crisis: A Case Study.	J Alzheimers Dis Rep
33283036	The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated response.	Alzheimers Dement (N Y)
33278917	Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study.	Lancet Public Health
33254580	Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.	Med Hypotheses
33254494	Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.	Med Hypotheses
33252083	Alzheimer's Disease and Face Masks in Times of COVID-19.	J Alzheimers Dis
33252073	Implementing Delirium Prevention in the Era of COVID-19.	J Alzheimers Dis
33250792	Selecting Remote Measurement Technologies to Optimize Assessment of Function in Early Alzheimer's Disease: A Case Study.	Front Psychiatry
33233425	ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.	J Clin Med
33225041	Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy.	Alzheimers Dement (Amst)
33212413	COVID-19 as a risk factor for Alzheimer's disease and related dementia: A perspective from Detroit, MI.	Psychiatry Res
33200104	Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders?	eNeurologicalSci
33193009	Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.	Front Neurol
33192733	Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline.	Front Psychiatry
33192732	The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review.	Front Psychiatry
33192483	Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.	Front Aging Neurosci
33185627	Addressing the Needs of Rural Caregivers of Individuals With Alzheimer's Disease and Related Dementias During and Beyond Coronavirus Disease 2019 (COVID-19).	Public Policy Aging Rep
33185608	COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder.	J Alzheimers Dis
33185582	COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?	Rev Neurosci
33177481	Long-Term Respiratory and Neurological Sequelae of COVID-19.	Med Sci Monit
33163611	A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID-19.	Alzheimers Dement (N Y)
33148439	Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study.	Brain Behav Immun
33146371	ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.	Clin Sci (Lond)
33132939	Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions.	Front Psychiatry
33132936	Effectively Caring for Individuals With Behavioral and Psychological Symptoms of Dementia During the COVID-19 Pandemic.	Front Psychiatry
33123943	[Position paper of the Austrian Alzheimer Association (Osterreichische Alzheimer Gesellschaft, OAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies].	Neuropsychiatr
33098588	Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma.	Biofactors
33083514	COVID-19, physical (in-)activity, and dementia prevention.	Alzheimers Dement (N Y)
33078369	Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease.	Mol Neurobiol
33075205	Are we measuring the same thing? Psychometric and research considerations when adopting new testing modes in the time of COVID-19.	Alzheimers Dement
33074266	The cognitive consequences of the COVID-19 epidemic: collateral damage?	Brain Commun
33074241	Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.	J Alzheimers Dis
33074240	Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.	J Alzheimers Dis
33074239	Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.	J Alzheimers Dis
33072845	e-Mental health care for people living with dementia: A lesson on digital equality from COVID-19.	Alzheimers Dement (Amst)
33072648	Can Infection of COVID-19 Virus Exacerbate Alzheimer's Symptoms? Hypothetic Possible Role of Angiotensin-Converting Enzyme-2/Mas/ Brain-Derived Neurotrophic Factor Axis and Tau Hyper-phosphorylation.	Adv Biomed Res
33061868	Beyond cardiovascular medicine: potential future uses of icosapent ethyl.	Eur Heart J Suppl
33044186	Burnout of Healthcare Workers in Acute Care Geriatric Facilities During the COVID-19 Crisis: An Online-Based Study.	J Alzheimers Dis
33041963	Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic.	Front Neurol
33033486	Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia.	Front Psychiatry
33023673	Reflections on the IJHPR's article collection on dementia.	Isr J Health Policy Res
33006226	Recognition of the coronavirus disease 2019 pandemic and face mask wearing in patients with Alzheimer's disease: an investigation at a medical centre for dementia in Japan.	Psychogeriatrics
33005158	COVID-19 Epidemic in Argentina: Worsening of Behavioral Symptoms in Elderly Subjects With Dementia Living in the Community.	Front Psychiatry
32999916	Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19.	Alzheimers Dement (Amst)
32987701	Mitochondrial Glutathione: Recent Insights and Role in Disease.	Antioxidants (Basel)
32987038	Neprilysin expression and functions in development, ageing and disease.	Mech Ageing Dev
32986671	Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundacio ACE in Barcelona, Spain.	J Alzheimers Dis
32981462	The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.	Neuroscientist
32969235	Neuropsychological and Functional Impact of COVID-19 on Mild Cognitive Impairment.	Am J Alzheimers Dis Other Demen
32955466	Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.	J Alzheimers Dis
32954710	Population Risk Factors for COVID-19 Mortality in 93 Countries.	J Epidemiol Glob Health
32954020	Hemorrhagic stroke and COVID-19 infection: Coincidence or causality?	eNeurologicalSci
32925078	COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.	J Alzheimers Dis
32925073	Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.	J Alzheimers Dis
32921678	Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.	Int Heart J
32921515	COVID-19 and the forgotten pandemic: follow-up of neurocognitive disorders during lockdown in Argentina.	Neurologia (Engl Ed)
32920637	Toulouse Alzheimer's Clinical Research Center Recovery after the COVID-19 Crisis: Telemedicine an Innovative Solution for Clinical Research during the Coronavirus Pandemic.	J Prev Alzheimers Dis
32920634	The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline.	J Prev Alzheimers Dis
32904792	Pandemic Dementia Scarce Resource Allocation.	Can Geriatr J
32904665	Dementia and COVID-19 Lockdown: More Than a Double Blow for Patients and Caregivers.	J Alzheimers Dis Rep
32885022	Transition from physical to virtual visit format for a longitudinal brain aging study, in response to the Covid-19 pandemic. Operationalizing adaptive methods and challenges.	Alzheimers Dement (N Y)
32869183	Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.	Mol Neurobiol
32839380	Impact of COVID-19 on Alzheimer's Disease Risk: Viewpoint for Research Action.	Healthcare (Basel)
32837118	Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy.	Struct Chem
32824985	4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.	Int J Mol Sci
32812440	Dementia and COVID-19: The Ones Not to Be Forgotten.	Am J Alzheimers Dis Other Demen
32804145	Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer's Disease Sleep Disorders.	J Alzheimers Dis
32804094	Resilience of Alzheimer's Disease to COVID-19.	J Alzheimers Dis
32789951	Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.	Alzheimers Dement
32775600	Will ""social distancing"" lead to future ""research distancing"": A reflection on COVID-19 impacts on Alzheimer's disease research.	Alzheimers Dement (N Y)
32767925	Direct Targets and Subsequent Pathways for Molecular Hydrogen to Exert Multiple Functions: Focusing on Interventions in Radical Reactions.	Curr Pharm Des
32763552	High depression and anxiety in people with Alzheimer's disease living in retirement homes during the covid-19 crisis.	Psychiatry Res
32745512	Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.	Lancet Public Health
32743933	Association launches webinar series for researchers.	Alzheimers Dement
32729446	Living with dementia: increased level of caregiver stress in times of COVID-19.	Int Psychogeriatr
32715280	Neurologic and Immunologic Complications of COVID-19: Potential Long-Term Risk Factors for Alzheimer's Disease.	J Alzheimers Dis Rep
32704352	Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.	F1000Res
32699671	Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?	Cureus
32691236	A systematic review of neurological symptoms and complications of COVID-19.	J Neurol
32686219	Senolytic drugs: from discovery to translation.	J Intern Med
32664217	Effects of Airborne Nanoparticles on the Nervous System: Amyloid Protein Aggregation, Neurodegeneration and Neurodegenerative Diseases.	Nanomaterials (Basel)
32662982	Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.	ACS Chem Neurosci
32661235	Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.	Signal Transduct Target Ther
32651328	Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.	J Alzheimers Dis
32651326	Dementia Care in the Time of COVID-19 Pandemic.	J Alzheimers Dis
32643133	Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study.	Neurol Sci
32640331	Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.	Food Chem Toxicol
32623403	Alzheimer's Disease Patients in the Crosshairs of COVID-19.	J Alzheimers Dis
32619698	Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.	J Infect
32603829	SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.	Biochim Biophys Acta Mol Basis Dis
32593196	The another side of COVID-19 in Alzheimer's disease patients: Drug-drug interactions.	Int J Clin Pract
32568212	Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19.	J Alzheimers Dis
32568211	The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.	J Alzheimers Dis
32554346	[Ethics, care and ageing during the Covid-19 pandemic].	Geriatr Psychol Neuropsychiatr Vieil
32538858	Dementia in the COVID-19 Period.	J Alzheimers Dis
32538857	Neurobiology of COVID-19.	J Alzheimers Dis
32538856	Dementia Care in Times of COVID-19: Experience at Fundacio ACE in Barcelona, Spain.	J Alzheimers Dis
32538855	Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.	J Alzheimers Dis
32534451	Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?	Aging (Albany NY)
32507686	Clinical Trials and Tribulations in the COVID-19 Era.	Am J Geriatr Psychiatry
32498691	Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.	Alzheimers Res Ther
32463074	Viewpoint: Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer's Disease Center Facing the Covid-19 Crisis.	J Prev Alzheimers Dis
32449791	Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.	Eur J Neurol
32381283	Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.	Am J Geriatr Psychiatry
32361337	Facetime to reduce behavioral problems in a nursing home resident with Alzheimer's dementia during COVID-19.	Psychiatry Res
32331845	Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.	Am J Geriatr Psychiatry
32202041	Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2.	Alzheimers Dement
"	
